SCHEMBL4541900

SCHEMBL4541900

O=C(NCc1ccc(Oc2ccc(F)cn2)cc1)c1cccn1-c1ncc(Cl)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
PPARG P37231 1/20 0.47
KMT2A Q03164 1/20 0.47
NR2E3 Q9Y5X4 1/20 0.47
NCOR2 Q9Y618 1/20 0.47
PTGER4 P35408 2/20 0.47
PTGER2 P43116 1/20 0.47
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
EGLN1 Q9GZT9 1/20 0.42
CNR2 P34972 1/20 0.42
P2RX3 P56373 9/20 0.41
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4543653 0.95 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4542797 0.92 PTGER4 (0.52) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4542706 0.89 MEN1 (0.57) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4539824 0.88 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4543969 0.87 CYP1A2 (0.49) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4536923 0.87 PPARG (0.49) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4542935 0.87 PPARG (0.49) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4542851 0.86 MEN1 (0.52) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4541439 0.86 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4542788 0.86 MEN1 (0.51) MEN1PPARGKMT2ANR2E3NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed